HOSPITAL UNIVERSITARIO RUBER
Departamento
Hiroshima University Hospital
Hiroshima, JapónPublicaciones en colaboración con investigadores/as de Hiroshima University Hospital (1)
2020
-
Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)
Journal of Clinical Oncology, Vol. 38, Núm. 34, pp. 3987-3998